touchLearning Activities
Our Editorial Board supports our mission to advance medical knowledge and practice by ensuring the integrity, relevance and impact of the content we publish. Together, we strive to foster a vibrant academic community and contribute to the continuous improvement of ...
European Parliament Establishes the Intergroup on Cancer & Rare Diseases The European Parliament has taken a landmark step in prioritizing cancer and rare disease policies by launching the new Intergroup on Cancer & Rare Diseases for the 2024-2029 legislative period. ...
What’s new in GI oncology? With the 2025 ASCO Gastrointestinal Cancers Symposium still fresh in our minds, we hear from leading experts on the key abstracts and presentations from the conference in the fields of colorectal and pancreatic cancer. Circulating ...
World Cancer Day is a campaign run by the Union for International Cancer Control (UICC). It is observed annually on February 4th, and unites the world in the fight against cancer. The theme for 2025–27, "United by Unique", highlights the individual ...
"While groundbreaking treatments are transformative, patients often remember the kindness and humanity of their oncologist more than the medicine they receive" Introducing our Future Leaders series, in this interview Dr Rodrigo Munhoz (Oncology Center – Hospital Sírio-Libanês in Sã...
"A mentor once told me to always stay true to my values – advice that has guided me throughout my career" Dr Eric Lander (Director of Research at Minnesota Oncology – Minneapolis, MN, USA) shares his journey and insights into the ...
In this interview, we are joined by President-Elect of the European Cancer Organisation (ECO), Dr Isabel Teresa Rubio (Head of Breast Surgical Oncology at Clínica Universidad de Navarra, Professor of Surgery at the University of Navarra, Spain). She discusses ...
7 January 2025, Brussels - The European Cancer Organisation (ECO) is pleased to announce the appointment of Elisabetta Zanon as its new Chief Executive Officer, effective 3 February. Elisabetta is a senior professional with more than 20 years of experience in European affairs, much ...
Professor Geerard Beets, President of the European Society of Surgical Oncology (ESSO), is a distinguished leader in surgical oncology and colorectal cancer research. With an impressive career spanning roles at Maastricht University Medical Centre and The Netherlands Cancer Institute, ...
As 2024 draws to a close, we’re celebrating a wonderful year of content.
In this interview, Dr Michael K. Gibson (Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA), an expert in head and neck and gastrointestinal (GI) oncology shares his personal journey, reflecting on how early experiences with cancer shaped his ...
Project Cure CRC, the breakthrough research fund of the leading nonprofit Colorectal Cancer Alliance (Alliance), has announced five new awardees of funds to advance urgent science in the colorectal cancer space. To date, 10 research grants have been awarded for a ...
Prof. Pierre Fenaux, Head of the Department of Hematology and Immunology at Assistance Publique-Hôpitaux de Paris Nord (Hôpitaux Saint-Louis, R Debré, Avicenne) is a leading expert in haematology with extensive experience in the treatment and management of myelodysplastic syndromes (MDS). In this interview, he discusses key considerations for first-line therapies in lower-risk MDS, the latest advances in treatment and the role of organizations like the European School of Hematology (ESH) in supporting haematologists.
The COVID-19 pandemic accelerated the development of mRNA technologies, most notably with the creation of mRNA vaccines targeting SARS-CoV-2. While these vaccines helped control the pandemic, their potential may extend beyond infectious diseases, with growing interest in their potential application ...
We’re thrilled to welcome Dr. Ken Kato (National Cancer Center Hospital, Tokyo, Japan) to discuss the unique advantages and challenges of conducting cancer research in Japan. Key advantages include robust regulatory support, streamlined trial approvals and strong collaboration with ...
Liver cancer remains a significant global health challenge, often going undetected until it has progressed to advanced stages. A major barrier to early detection is the lack of awareness about liver health and risk factors, such as chronic liver diseases ...
touchONCOLOGY
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
